combination chemotherapy improved survival significantly more than single-agent chemotherapy only for the patients with diffuse histiocytic lymphoma , not for those with diffuse poorly differentiated lymphocytic lymphoma or the more favourable histologic types of non-hodgkin 's lymphoma -- diffuse well differentiated lymphocytic and nodular poorly differentiated lymphocytic .
C2348518
favourable
C0024264
lymphocytic